| Overview |
| bsm-62186r-apc-cy55-100ul |
| CD155 Recombinant Antibody, APC-Cy5.5 Conjugated |
| WB |
| Human |
| Specifications |
| APC-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CD155 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5817 |
| P15151 |
| Secreted, Cell membrane |
| CD155; HVED; mE4; Necl5; PVR; PVS; Taa1; TAGE4. |
| Mediates NK cell adhesion and triggers NK cell effector functions. Binds two different NK cell receptors: CD96 and CD226. These interactions accumulates at the cell-cell contact site, leading to the formation of a mature immunological synapse between NK cell and target cell. |
| Application Dilution |
| WB |
=1:500-2000 |
Powered by Bioz